Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AVITA Medical (RCEL) EBT (2018 - 2025)

Historic EBT for AVITA Medical (RCEL) over the last 8 years, with Q4 2025 value amounting to -$11.6 million.

  • AVITA Medical's EBT fell 58.77% to -$11.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$48.6 million, marking a year-over-year increase of 2138.5%. This contributed to the annual value of -$48.6 million for FY2025, which is 2138.66% up from last year.
  • AVITA Medical's EBT amounted to -$11.6 million in Q4 2025, which was down 58.77% from -$13.2 million recorded in Q3 2025.
  • In the past 5 years, AVITA Medical's EBT ranged from a high of -$4.7 million in Q2 2021 and a low of -$18.6 million during Q1 2024
  • Over the past 5 years, AVITA Medical's median EBT value was -$9.9 million (recorded in 2025), while the average stood at -$10.4 million.
  • In the last 5 years, AVITA Medical's EBT skyrocketed by 6350.89% in 2021 and then tumbled by 20067.72% in 2023.
  • Over the past 5 years, AVITA Medical's EBT (Quarter) stood at -$5.9 million in 2021, then rose by 8.04% to -$5.5 million in 2022, then crashed by 200.68% to -$16.4 million in 2023, then increased by 29.58% to -$11.6 million in 2024, then decreased by 0.59% to -$11.6 million in 2025.
  • Its EBT stands at -$11.6 million for Q4 2025, versus -$13.2 million for Q3 2025 and -$9.9 million for Q2 2025.